Two students have been awarded INPhINIT grants by “la Caixa” Foundation to complete their PhDs on the Can Ruti Campus. Emma Koehorst, has been working on Myotonic Dystrophy in the Neuromuscular and Neuropaediatric research group led by Gisela Nogales at the IGTP since last September. Ifeanyi Ezeonwumelu has started working at the IrsiCaixa on novel therapeutic strategies for HIV with Dr Ester Ballana Guix in the HIV Pathogenesis Group, led by Dr José A Esté.
At the IGTP TODAY
This July the Government of Catalonia officially approved the Plan for Prevention and Control of Hepatitis in Catalonia, which aims to facilitate the adoption and implementation of measures to reduce the number of cases and the morbidity and mortality associated with this infection. This is in line with the goal of the WHO, which aims to eliminate hepatitis C by 2030. The plan is the result of healthcare and public health professionals, experts, representatives of scientific societies and organizations and patients and families associations all working together.
The Director of the Germans Trias I Pujol Research Institute (IGTP), Manel Puig and the Director of the Instituto de Salud Carlos III, Raquel Yotti have put their formal seal on the starting up of the Comparative Medicine and Bioimage Centre of Catalonia (CMCiB). The CMCiB is a centre built on the Can Ruti Campus by the IGTP with the aim of being a reference centre for comparative medicine, bioimaging and computational models and a pioneer in applying alternative methods for biomedical research that impacts on the health of the population. The facilities of the centre include latest generation operating theatres that are adaptable for continued training, perfecting new surgical techniques and development of new surgical devices.
This June saw the successful close of the fifth edition of the Postgraduate Course in Research and Innovation in Health Sciences. 21 professionals undergoing their medical training (medicine, nursing, pharmacy and so on) presented their final dissertations for the course, which is organized by the Maresme Health Consortium (CSdM) and the Universitat Autònoma de Barcelona (UAB) with the support of the IGTP, the Germans Trias Hospital.
The Islet Regulome Browser, developed by IGTP scientists, brings genomic data to life for diabetes researchers
The paper "Human pancreatic islet 3D chromatin architecture provides insights into the genetics of type 2 diabetes" published in Nature Genetics on Friday is the result of work carried out by an International team that includes Dr Lorenzo Pasquali and Mireia Ramos-Rodríguez of the Endocrine Regulatory Genomics Research Group at the Germans Trias i Pujol Research Institute and the Josep Carreras Leukaemia Research Institute. Pasquali's group has provided their tool, the Islet Regulome Browser, which allows non-bioinformaticians to visualize and use all the data collected in this study. The work brings personalized medicine for type 2 diabetes a little closer.
The Ministry of Health presented the grants for the 2018 and 2019 calls of the Strategic Plan for Innovation in Health (PERIS) on Tuesday. In this year's round the Germans Trias neurologist Natalia Pérez de la Ossa received a grant for the project for pre-hospitalization healthcare for patients with acute stroke. The doctor Daniel Fuster was also awarded a grant for the second edition, which he received at the same ceremony.
This Thursday the Llavaneres Golf Club hosted the 1st Pep Anglès Golf Tournament, a charity event for the Amics de Can Ruti (Friends of Can Ruti) and research at the IGTP. It is the first edition of the fundraising event organized by the player and his club and more than 10,000 euros have been raised for research into childhood diabetes at Can Ruti.
In a brand new format, scientists come together to share and discuss research on the Can Ruti Campus in the First IGTP PI Retreat
Principal investigators from the nine areas of research on the Can Ruti Campus met together to discuss topics of concern in the current research environment. During the day, researchers enjoyed inputs from the IGTP research community and external speakers and were able to take advantage of the many moments available for networking and sharing.
The IGTP Biobank renews its European certification from the Biorepository Proficiency Testing Program
This is the third round of evaluations the IGTP-HGTP Biobank has undertaken to ensure and certify the quality of its services. The Biorepository Proficiency Testing Program is a voluntary external evaluation programme, with members from several countries. Once again, the IGTP-HTP Biobank has been awarded the certificate, opting to apply every two years.
A new tool that makes it possible to adapt treatment for patients with cardiogenic shock has been discovered
Cardiogenic shock is a possible complication of serious heart attack involving an associated mortality rate of approximately 50% of all cases. The combination of this new tool with existing methods renders precise and patient-specific decision-making possible. The research is being led by Dr. Antoni Bayés at Germans Trias and the Proteomics Unit of the CRG and UPF, under Dr. Eduard Sabidó